Latest filing published 18 Feb 2026 for Evommune, Inc., €8.4M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -63.5%Entry US$18.22 · Close 06 Nov 2026 US$6.65
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Weegen Felice Isabel Verduyn-van: trading record in brief
All filings by Weegen Felice Isabel Verduyn-van on record concern Evommune, Inc. In total, 3 filings cover trades dated from 7 November 2025 to 17 February 2026.
Every open-market trade on record is a purchase: 1 purchase worth €21.6M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant.
The record was last updated on 18 February 2026 with a share grant (€8.4M) in Evommune, Inc. The latest purchase dates back some time: it was published 361 days ago, on 12 November 2025. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Weegen Felice Isabel Verduyn-van
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 358,680 shares@ US$27.88100.0% of flowCommon StockSEC:0002094941-26-000002:0
- 1,562,500 shares@ US$16.0072.0% of flowCommon StockSEC:0002094941-25-000004:1Canonical exit: 5 Feb 2026 (T+90)
- 3,367,133 sharesCommon StockSEC:0002094941-25-000004:0
3 of 3 declarations